LATEST DEVELOPMENTS
206 filings Chronological · ET
SNTI
SENTI BIOSCIENCES Files Amended Terms for Senior Secured Convertible Notes
An 8-K discloses a revised form of senior secured convertible note maturing November 23, 2026, repayable in cash at 200% of outstanding principal.
8 days ago
PRO
BSP
BENDING SPOONS Completes Acquisition of Airtable
The Milan-based app owner closed its previously announced purchase of all outstanding shares of Formagrid, the company behind Airtable, on September 4.
8 days ago
PRO
LND
BRASILAGRO Guides to 452,900 Tons for 2026/27 as El Niño Reshapes Crop Mix
The Brazilian farmland operator plans 165,208 hectares next season, cutting first-crop cotton 70% and dropping second-crop beans while lifting corn and pasture.
8 days ago
PRO
KXIN
KAIXIN Doubles Share Payout for Taohaoche Deal After 70% Stock Slide
Kaixin will issue 10 million extra Class A shares to the seller of Hongkong Taohaoche after its stock fell from above $5.00 to under $1.50.
8 days ago
PRO
EGAN
EGAIN Guides Fiscal 2027 Revenue Below Fiscal 2026 as Legacy Business Shrinks
eGain grew fiscal 2026 revenue 3% to $91.1 million and lifted AI customer revenue 20%, but guided fiscal 2027 sales down to $84.5-$86.0 million.
8 days ago
PRO
ALB
ALBEMARLE Names BHP Executive Ragnar Udd as CEO From February 2027
Kent Masters hands over the CEO role to BHP's chief commercial officer and becomes executive chairman of the lithium producer.
8 days ago
PRO
NCPL
NETCAPITAL Director Quits, Citing SEC Fraud Suit Against Company and Officers
A Netcapital board member resigned immediately over the SEC's August 10 civil action and demanded D&O insurance and indemnification records within 10 business days.
8 days ago
PRO
USAR
USA RARE EARTH Closes Serra Verde Deal After Second Merger Amendment
The 8-K reports a completed acquisition, new debt, unregistered share issuance and a board change, alongside a September 3 amendment to the Serra Verde merger agreement.
8 days ago
PRO
TARS
TARSUS Closes Alkeus Deal, Adding Phase 3 Stargardt Drug
Tarsus Pharmaceuticals has completed its acquisition of Alkeus, gaining worldwide rights to oral Stargardt disease candidate gildeuretinol.
8 days ago
PRO
NTLA
INTELLIA Lands Up to $400M Non-Dilutive Debt Facility From OrbiMed
The CRISPR company drew $75 million at closing, with $325 million more tied to milestones ahead of a planned U.S. launch of lonvo-z in hereditary angioedema.
8 days ago
PRO
OXM
OXFORD INDUSTRIES Cuts Fiscal 2026 Guidance as Lilly Pulitzer Sales Slip
Tommy Bahama's owner posted $394M in Q2 sales and a $42M tariff refund boost, but lowered full-year sales and adjusted EPS guidance.
8 days ago
PRO
DPU
TOP KINGWIN Holders Approve 1-for-50 Reverse Split and Nexpu Name Change
Shareholders backed a 200x supervoting Class B structure, a jump in authorized capital to $625 million and a share consolidation effective December 17, 2026.
8 days ago
PRO
SWBI
SMITH & WESSON Sales Jump 32% as Q1 Swings to Profit
Firearm maker posted $112.6 million in fiscal Q1 net sales and $0.06 EPS versus a loss a year ago, and guided to roughly 10% sales growth in Q2.
8 days ago
PRO
PCVX
VAXCYTE Hires Ex-Pfizer Vaccine Chief, Narrows VAX-31 Data Timing
Vaxcyte named Luis Jodar CMO and David McAvoy CLO, and now expects OPUS-1 Phase 3 topline data by the end of October 2026.
8 days ago
PRO
AMBA
AMBARELLA Posts 13% Revenue Growth and Guides Q3 Above $115M
The edge AI chipmaker reported $108.1 million in fiscal Q2 revenue, narrowed its GAAP loss to $6.7 million and guided to $115-124 million for Q3.
8 days ago
PRO
NPWR
NET POWER Closes Deal for 123 MW of Gas Generation at Project Permian
Net Power acquired EMPower's position under an EPC agreement with Saulsbury, lifting phase-one capacity at its West Texas powered land project to nearly 200 MW.
8 days ago
PRO
MAMA
MAMA'S CREATIONS Revenue Jumps 55% to $54.6M as Net Income Doubles
The deli foods maker posted $54.6 million in fiscal Q2 revenue, doubled net income to $2.6 million and ended the quarter with $138.6 million in cash.
8 days ago
PRO
BILI
BILIBILI Prices $700M Convertible Notes With Tencent Taking $200M
Bilibili sells zero-coupon 2031 converts at a 28.3% premium, funds up to $300M in buybacks, while Tencent subscribes $200M and sells 26.4 million shares.
8 days ago
PRO
DOCU
DOCUSIGN Lifts FY27 Outlook as IAM Reaches 15.1% of ARR
Q2 revenue rose 9% to $875.7 million, free cash flow hit $295.8 million, and Docusign raised full-year revenue and ARR guidance on AI-driven IAM adoption.
8 days ago
PRO
IOT
SAMSARA Crosses $2.1 Billion ARR With 30% Growth in Q2 FY2027
The connected operations software maker posted $508.4 million in quarterly revenue, its fourth straight quarter of GAAP profitability, and guided Q3 revenue to about $515 million.
8 days ago
PRO
PATH
UIPATH Posts 13% Revenue Growth and Promotes Ramani to CFO
Fiscal Q2 revenue of $410 million and ARR of $1.938 billion beat guidance as UiPath reshuffles its executive team and adds a board member.
8 days ago
PRO
SOUN
SOUNDHOUND AI Closes LivePerson Deal and Names John Collins CFO
SoundHound AI completed its acquisition of LivePerson, retired its debt and appointed former LivePerson finance chief John Collins as CFO.
8 days ago
PRO
FLEX
FLEX to Buy EPC Power in $4.4 Billion Stock Purchase Deal
Flex unit ACS Acquisitions agreed to buy all shares of inverter maker EPC Power Corp. from Charge Parent for $4.4 billion, with Flex guaranteeing the deal.
8 days ago
PRO
IONS
FDA Approves IONIS Drug Zanvastro for Alexander Disease
Ionis wins first-ever approval for a disease-modifying Alexander disease therapy, plus a rare pediatric disease priority review voucher.
8 days ago
PRO
MAX
MEDIAALPHA Swaps CFOs and Says Q3 Will Top Guidance
Pat Thompson steps down as CFO on October 1; predecessor Tigran Sinanyan returns, while the company says Q3 revenue, contribution and adjusted EBITDA will be at or above the top of guidance.
9 days ago
PRO
NLST
NETLIST Loses Three Federal Circuit Appeals Against Micron on Same Day
The Federal Circuit affirmed PTAB rulings invalidating claims of five Netlist memory patents challenged by Micron, including one precedential decision.
9 days ago
PRO
PSNY
POLESTAR Posts $842M Half-Year Loss as Revenue Slips 4.4%
The EV maker cut its net loss by 29% in H1 2026, but adjusted EBITDA worsened to a loss of $521 million while deliveries were roughly flat.
9 days ago
PRO
APGE
APOGEE THERAPEUTICS Buyout Closes as Shares Head for Delisting
An 8-K filing shows Apogee Therapeutics has completed a change-of-control transaction, replaced its board and recapitalized to just 1,000 shares.
9 days ago
PRO
CIEN
CIENA Revenue Jumps 37% to $1.67B as AI Drives Optical Demand
Ciena posted record fiscal Q3 revenue of $1.67 billion and adjusted EPS of $2.11, and raised its full-year revenue outlook to $6.42 billion.
9 days ago
PRO
CPB
CAMPBELL'S Cuts Dividend 36% and Guides FY27 EPS Down as Much as 24%
Q4 adjusted EPS fell 37% to $0.39, the quarterly payout drops to $0.25, and Campbell's targets $500 million in cost savings by fiscal 2030.
9 days ago
PRO
NESR
NESR CEO Sherif Foda Sells $3.5M in Stock, Gifts 675,000 Shares
National Energy Services Reunited's chief executive sold 100,000 ordinary shares at $35.00 and transferred another 675,000 shares as a gift.
10 days ago
PRO
ESTC
ELASTIC Founder Shay Banon Sells $44.5M in Shares Over Three Days
Elastic's CTO and co-founder disposed of about 476,000 ordinary shares between August 31 and September 2, cutting his stake to roughly 1.58 million shares.
10 days ago
PRO
CRWD
CrowdStrike Co-Founder Kurtz and Director Gandhi Sell $8.8M in Stock
Two CrowdStrike insiders sold a combined 40,000 Class A shares on Aug. 31 and Sept. 1 at prices between roughly $213 and $234.
10 days ago
PRO
AUGO
Aura Minerals Director Sells $10.4 Million of Shares in Open Market
A Form 4 shows director Bruno Sousa Mauad sold 127,500 Aura Minerals shares at $81.20 apiece on Aug. 31, cutting his stake by more than 40%.
10 days ago
PRO
ABT
FDA Authorizes First Dual Glucose and Ketone Wearable, Abbott's Libre Duo
The FDA cleared the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people with diabetes aged 2 and older.
10 days ago
PRO
RVMD
FDA Approves Rasonque, First RAS Inhibitor for Metastatic Pancreatic Cancer
The FDA cleared daraxonrasib for the most common form of advanced pancreatic cancer, acting months ahead of its review deadline.
10 days ago
PRO
ROIV
FDA Approves Lisraya, First Oral Drug for Dermatomyositis in Adults
The FDA has cleared Lisraya (brepocitinib) tablets, the first oral therapy specifically indicated for adults with dermatomyositis.
10 days ago
PRO
PTGX
FDA Approves Mimrylo (Rusfertide), First Hepcidin Mimetic for Polycythemia Vera
The FDA has cleared Mimrylo (rusfertide) for adults with polycythemia vera, calling it the first drug of its kind for the rare blood disorder.
10 days ago
PRO
DH
Advent Offers $1.02 a Share to Take Definitive Healthcare (DH) Private
A special committee of independent directors confirmed a non-binding all-cash proposal from Advent International for all shares it does not already own.
10 days ago
PRO
ABI
Abcourt Closes US$10M Debenture Upsize With Glencore, Repays Nebari Loan
Abcourt Mines lifted its Glencore senior secured debenture to US$40 million, drew US$19.875 million and repaid a US$12 million Nebari credit facility.
10 days ago
PRO
No filings match.Try another ticker or clear the filter.